Hematopoietic Stem-Cell Transplantation for the Treatment of Beta Thalassemia

Pediatric Hematopoietic Stem Cell Transplantation

Volumn , Issue , 2006, Pages 383-396

  Boulad, Farid ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85134934715     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780849358807-23     Document Type: Chapter

References (93)

1. Collins FS, Weissman SM. The molecular genetics of human hemoglobin. Prog Nucl Acid Res Mol Biol 1984; 31:3.
2. Arcasoy MO, Gallagher PG. Molecular diagnosis of hemoglobinopathies and other red blood cell disorders. Semin Hematol 1999; 36:328-339.
3. Schwartz E, Cohen A, Surrey S. Overview of the beta thalassemias; genetic and clinical aspects. Hemoglobin 1988; 12:551-564.
4. Nathan DG, Gunn RB. Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am J Med 1966; 41:8.
5. Nathan DG, Stossel TB. Influence of hemoglobin precipitation on erythrocyte metabolism in a and b-thalassemia. J Clin Invest 1969; 48:33.
6. Fessas P. Inclusions of hemoglobin in erythroblasts and erythrocytes of thalassemia. Blood 1963; 21:2.
7. Giardina PJ, Hilgartner HW. Update on thalassemia. Pediatr Rev 1992; 13:55.
8. Lo L, Singer ST. Thalassemia: current approach for an old disease. Ped Clin North America 2002; 49:1165-1191.
9. Calleja EM, Shen JY, Lesser M, Grady RW, New MI, Giardina PJ. Survival and morbidity in transfusion-dependent thalassemia patients on subcutaneous desferioxamine chelation. Nearly two decades of experience. Ann N Y Acad Sci 1998; 850:469-470.
10. Dover GJ. Hemoglobin switching protocols in thalassemia. Experience with sodium phenyl butyrate and hydroxyurea. Ann N Y Acad Sci Jun 30 1998; 850:80-86.
11. Sadelain M, Rivella S, Lisowski L, Samakoglu S, Riviere I. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease. Best Pract Res Clin Haematol 2004.
12. Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassaemia. Lancet 1982; 2:227-229.
13. Brochstein JA, Kirkpatrick D, Giardina PJ, et al. Bone marrow transplantation in two multiply transfused patients with thalassaemia major. Br J Haematol 1986; 63:445-456.
14. Lucarelli G, Polchi P, Izzi T, et al. Allogeneic marrow transplantation for thalassemia. Exp Hematol 1984; 12:676-681.
15. Lucarelli G, Polchi P, Galimberti M, et al. Marrow transplantation for thalassaemia following busulphan and cyclophosphamide. Lancet 1985; 1:1355-1357.
16. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with advanced thalassemia. N Engl J Med 1987; 316:1050-1055.
17. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322:417-421.
18. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in thalassemia. Hematol Oncol Clin North Am 1991; 5:549-556.
19. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in adult thalassemia. Blood 1992; 80:1603-1607.
20. Baronciani D, Galimberti M, Lucarelli G, et al. Bone marrow transplantation in class 1 thalassemia patients. Bone Marrow Transplant 1993; 12:56-58.
21. Giardini C, Galimberti M, Lucarelli G, Polchi P, Baronciani D, Angelucci E. Bone marrow transplantation in class 2 thalassemia patients. Bone Marrow Transplant 1993; 12:59-62.
22. Angelucci E, Baronciani D, Lucarelli G, et al. Bone marrow transplantation in class 3 thalassaemia patients. Bone Marrow Transplant 1993; 12:63-64.
23. Erer B, Galimberti M, Lucarelli G, et al. Bone marrow transplantation in adult thalassemia. Bone Marrow Transplant 1993; 12:65-66.
24. Lucarelli G, Clift RA, Galimberti M, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996; 87:2082-2088.
25. Andreani M, Manna M, Nesci S, Fattorini P, Graziosi G, Lucarelli G. Persistence of mixed chimerism in class 3 thalassemic patients following BMT. Bone Marrow Transplant 1991; 7:75.
26. Lucarelli G, Galimberti M, Giardini C, et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann NY Acad Sci 1998; 850:270-275.
27. Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia with bone marrow transplantation. Bone Marrow Transplant 2001; 28:S11-S13.
28. Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia by bone marrow transplantation. Blood Rev 2002; 16:81-85.
29. Gaziev D, Polchi P, Galimberti M, et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors. Transplantation 1997; 63:854-860.
30. Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry. Br J Haematol 2003; 121:938-948.
31. Sodani P, Gaziev D, Polchi P, et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004; 104:1201-1203.
32. Barrett AJ, Lucarelli G, Gale RP, Sobocinski A, Horowitz M, Bortin MM. Bone marrow transplantation for thalassaemia—a preliminary report from the international bone marrow transplant registry. Prog Clin Biol Res 1989; 309:173-185.
33. Hugh-Jones K, Vellodi A, Jones ST, Hobbs JR, Rogers JR, Abdul had A. Bone marrow transplantation for thalassaemia: Westminster children’s hospital and United Kingdom experience. Prog clin Biol Res 1989; 309:201-205.
34. Frappaz D, Gluckman E, Souillet G, et al. Bone marrow transplantation for thalassemia major. The French experience. Prog clin Biol Res 1989; 309:207-216.
35. Lin KH, Lin KS. Allogeneic one marrow transplantation for thalassemia in Taiwan: factors associated with graft failure. Am J Pediatr Hematol Oncol 1989; 11:417-423.
36. Clift RA. Marrow transplantation for thalassemia: the Seattle experience. Seattle marrow transplant team. Bone Marrow Transplant 1993; 12:47-48.
37. Issaragrisil S, Visudhisakchai S, Suvatte V, et al. Bone marrow transplantation for thalassemia in Thailand. Transplant Proc 1994; 26:2348-2349.
38. Vellodi A, Picton S, Downie CJ, Eltumi M, Stevens R, Evans DI. Bone marrow transplantation for thalassaemia: experience of two British centres. Bone Marrow Transplant 1994; 13:559-562.
39. Walters MC, Sullivan KM, O’Reilly RJ, et al. Bone marrow transplantation for thalassemia. The U.S.A. experience. Am J Pediatr Hematol Oncol 1994; 16:11-17.
40. Di Bartolomeo P, Di Girolamo G, Olioso P, et al. The Pescara experience of allogeneic bone marrow transplantation in thalassemia. Bone Marrow Transplant 1997; 19:48-53.
41. Li CK, Yuen PMP, Shing MK, et al. Stem cell transplant for thalassaemia patients in Hong Kong. Bone Marrow Transplant 1997; 19:62-67.
42. Graphacos S, Kitra V, Peristeri J, Goussetis E, Papadakis V. Haemopoietic transplantation for thalassaemic children: the Greek experience. Bone Marrow Transplant 1997; 19:68-69.
43. Dennison D, Srivastava A, Chandy M. Bone marrow transplantation for thalassaemia in India. Bone Marrow Transplant 1997; 19:70.
44. Lin HP, Chan LL, Lam SK, Ariffin W, Menaka N, Looi LM. Bone marrow transplantation for thalassaemia. The experience from Malaysia. Bone Marrow Transplant 1997; 19:74-76.
45. Boulad F, Giardina P, Gillio A, et al. Bone marrow transplantation for homozygous beta-thalassemia. The memorial Sloan-Kettering cancer center experience. Ann NY Acad Sci 1998; 850:498-502.
46. Ghavamzadeh A, Nasseri P, Eshraghian MR, et al. Prognostic factors in bone marrow transplantation for beta thalassemia major: experiences from Iran. Bone Marrow Transplant 1998; 22:1167-1169.
47. Lawson SE, Roberts IA, Amrolia P, Dokal I, Szydlo R, Darbyshire PJ. Bone marrow transplantation for beta-thalassaemia major: the U.K. experience in two paediatric centres. Br J Haematol 2003; 120:289-295.
48. Ball LM, Lankester AC, Giordano PC, et al. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience. Bone Marrow Transplant 2003; 31:1081-1087.
49. Lee YS, Kristovich KM, Ducore JM, et al. Bone marrow transplant in thalassemia. A role for radiation. Ann NY Acad Sci 1998; 850:503-505.
50. La Nasa G, Giardini C, Argiolu F, et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002; 99:4350-4356.
51. Hongeng S, Pakakasama S, Chaisiripoomkere W, et al. Outcome of transplantation with unrelated donor bone marrow in children with severe thalassaemia. Bone Marrow Transplant 2004; 33:377-379.
52. Gaziev D, Galimberti M, Lucarelli G, et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA non-identical sibling or parent transplants. Bone Marrow Transplant 2000; 25:815-821.
53. Miniero R, Rocha V, Saracco P, et al. Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord. Bone Marrow Transplant 1998; 22:S78-S79.
54. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101:2137-2143. Epub 2002 Nov 07.
55. Adamkiewicz TV, Mehta PS, Boyer MW, et al. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant 2004; 34:405-411.
56. Hall JG, Martin PL, Wood S, Kurtzberg J. Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major. J Pediatr Hematol Oncol 2004; 26:382-385.
57. Andreani M, Nesci S, Lucarelli G, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant 2000; 25:401-404.
58. Battaglia M, Andreani M, Manna M, et al. Coexistence of two functioning T-cell repertoires in healthy ex-thalassemics bearing a persistent mixed chimerism years after bone marrow transplantation. Blood 1999; 94:3432-3438.
59. Nesci S, Manna M, Andreani M, Fattorini P, Graziosi G, Lucarelli G. Mixed chimerism in thalassemic patients after bone marrow transplantation. Bone Marrow Transplant 1992; 10:143-146.
60. Or R, Naparstek E, Cividalli G, et al. Bone marrow transplantation in beta-thalassemia major. The Israeli experience. Hemoglobin 1988; 12:609-614.
61. Or R, Naparstek E, Aker M, et al. Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major. Prog Clin Biol Res 1989; 309:217-222.
62. Kapelushnik J, Or R, Filon D, et al. Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. Blood 1995; 86:3241-3246.
63. Naparstek E, Delukina M, Or R, et al. Engraftment of marrow allografts treated with campath-1 monoclonal antibodies. Exp Hematol 1999; 27:1210-1218.
64. Rosales F, Peylan-Ramu N, Cividalli G, et al. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases. Bone Marrow Transplant 1999; 23:861-865.
65. Yeisner Y, Martelli MF. Transplantation tolerance induced by “mega-dose” CD34+ stem cell transplants. Exp Hematol 2000; 28:119-127.
66. Aker M, Kapelushnik J, Pugatsch T, et al. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major. J Pediatr Hematol Oncol 1998; 20:145-148.
67. Horan JT, Liesveld JL, Fenton P, Blumberg N, Walters MC. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant 2004:1-7.
68. Iannone R, Casella JF, Fuchs EJ, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003; 9:519-528.
69. Piga A, Longo F, Voi V, Facello S, Miniero R, Dresow B. Late effects of bone marrow transplantation for thalassemia. Ann NY Acad Sci 1998; 850:294-299.
70. Lucarelli G, Angelucci E, Giardini C, et al. Fate of iron stores in thalassaemia after bone-marrow transplantation. Lancet 1993; 342:1388-1391.
71. Giardini C, Galimberti M, Lucarelli G, et al. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia. Br J Haematol 1995; 89:868-873.
72. Giardini C, Galimberti M, Lucarelli G, et al. Desferioxamine therapy of secondary hemochromatosis after BMT for thalassemia. Bone Marrow Transplant 1997; 19:119-122.
73. Angelucci E, Muretto P, Lucarelli G, et al. Treatment of iron overload in the “ex-thalassemic.” Report from the phlebotomy program. Ann NY Acad Sci 1998; 850:288-293.
74. Angelucci E, Muretto P, Lucarelli G, et al. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian cooperative group for phlebotomy treatment of transplanted thalassemia patients. Blood 1997; 90:994-998.
75. Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343:327-331.
76. Angelucci E, Baronciani D, Lucarelli G, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995; 89:757-761.
77. Muretto P, Angelucci E, Lucarelli G. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Ann Intern Med 2002; 136:667-672.
78. Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002; 100:17-21.
79. Erer B, Angelucci E, Lucarelli G, et al. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14:369-372.
80. Giardini C, Galimberti M, Lucarelli G, et al. Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia. Bone Marrow Transplant 1997; 20:767-772.
81. Wonke B, Telfer P, Garson JA, et al. Alpha-interferon alone and in combination with ribavirin for hepatitis C infection in multiply transfused patients with thalassemia major—the U.K. experience. Bone Marrow Transplant 1997; 19:163-165.
82. Mariotti E, Agostini A, Angelucci E, Lucarelli G, Sgarbi E. Reversal of the initial cardiac damage in thalassemic patients treated with bone marrow transplantation and phlebotomy. Bone Marrow Transplant 1997; 19:139-141.
83. Manenti F, Galimberti M, Lucarelli G, et al. Growth and endocrine function after bone marrow transplantation for thalassemia major. Prog Clin Biol Res 1989; 309:273-280.
84. Mariotti E, Agostini A, Angelucci E, Lucarelli G, Sgarbi E. Echocardiographic study in ex-thalassemic patients with iron overload, preliminary observations during phlebotomy therapy. Bone Marrow Transplant 1993; 12:106-107.
85. Li CK, Chik KW, Wong GW, Cheng PS, Lee V, Shing MM. Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol 2004; 21:411-419.
86. Galimberti M, De Sanctis V, Lucarelli G, et al. Endocrine function after bone marrow transplantation for thalassemia. Bone Marrow Transplant 1991; 7:74.
87. De Sanctis V, Galimberti M, Lucarelli G, et al. Pubertal development in thalassaemic patients after allogenic bone marrow transplantation. Eur J Pediatr 1993; 152:993-997.
88. De Sanctis V, Galimberti M, Lucarelli G, Polchi P, Ruggiero L, Vullo C. Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child 1991; 66:517-520.
89. Ogilvy-Stuart AL, Shalet SM. Gonadal function after allogeneic bone marrow transplantation for thalassaemia. Arch Dis Child 1991; 66:1365-1366.
90. Ponte G, Ferrara M, Esposito L. Growth in homozygous beta-thalassemia after bone marrow transplantation. Bone Marrow Transplant 1991; 8:68-69.
91. Cohen A, van Lint MT, Uderzo C, et al. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood. Bone Marrow Transplant 1995; 15:343-348.
92. De Simone M, Olioso P, Di Bartolomeo P, et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant 1995; 15:227-233.
93. De Simone M, Di Bartolomeo P, Olioso P, et al. Growth after recombinant human growth hormone (rhGH) treatment in transplanted thalassemic patients. Bone Marrow Transplant 1997; 20:567-573.